Evidence map›Paper›PMID 39661467›Full record

ArticleMolecular biology of the cell2025

Zelda is dispensable for

Tommy O'Haren, Tsutomu Aoki, Leila E Rieder

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Tommy O'HarenDepartment of Biology, Emory University, Atlanta, GA 30322.ORCID 0000-0002-3172-4672
Tsutomu AokiDepartment of Molecular Biology, Princeton University, Princeton, NJ 08540.
Leila E RiederDepartment of Biology, Emory University, Atlanta, GA 30322.ORCID 0000-0001-9851-0145

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Developmental Regulation of Nuclear DomainsR35GM142724 · NIGMS · EMORY UNIVERSITY · PI Leila Elizabeth Rieder · 2021 to 2026
$2.6M
Developmental regulation of histone genes by pioneer factors and three-dimensional architectureF31HD108974 · NICHD · EMORY UNIVERSITY · PI O'HAREN, THOMAS E · 2023 to 2025
$146k
NCI NIH HHS P30 CA138292NICHD NIH HHS F31 HD108974NIGMS NIH HHS R35 GM142724NIGMS NIH HHS T32 GM007092NIGMS NIH HHS T32 GM008490NIH HHS P40 OD018537
6 · The paper itself

Abstract

To ensure that the embryo can package exponentially increasing amounts of DNA, replication-dependent histones are some of the earliest transcribed genes from the zygotic genome. However, how the histone genes are identified is not known. The

Indexed as

Drosophila melanogasterDrosophila ProteinsHistonesTranscription FactorsAnimalsEmbryonic DevelopmentEmbryo, NonmammalianGene Expression Regulation, DevelopmentalNuclear ProteinsRNA, MessengerZygoteDrosophila ProteinsHistonesNuclear ProteinsRNA, MessengerTranscription Factorszld protein, Drosophila

Identifiers

PMID39661467
PMCPMC11809315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.